placeholder image
T. R. Halfdanarson All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • A Phase II randomized trial of panitumumab, erlotinib, and gemcitabine versus rrlotinib and hemcitabine in patients with nntreated, metastatic pancreatic adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance). 
    The oncologist. 2019
    • Contact
    full name
  • T. R. Halfdanarson
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration